Commercial license to Synaffix technologies follows a series of successful initial preclinical proof of concept studiesCollaboration underscores Lonza's commitment to…
HOUSTON, Nov. 4, 2024 /PRNewswire/ -- OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer…
Epic now fully supports version 3 of the United States Core Data for Interoperability standards—over a year ahead of the…
Company Continues to Work with Securities Regulators, Legal Advisors and Other Partners to Protect Interests of Shareholders PLEASANTON, Calif., Nov.…
WELL to acquire Canadian clinical assets from Jack Nathan Medical Corp. including a network of 16 owned and operated…
BOCA RATON, Fla., Nov. 4, 2024 /PRNewswire/ -- HelixVM™, a leading innovator in asynchronous digital health care, is proud to…
LAUSANNE, Switzerland, Nov. 4, 2024 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field…
ATLANTA, Nov. 4, 2024 /PRNewswire/ -- Today Bark Technologies, the leading online safety company known for developing the award-winning Bark…
CINCINNATI, Nov. 4, 2024 /PRNewswire/ -- Sense Neuro Diagnostics, a leader in developing technology for the diagnosis and monitoring of brain…
NEW YORK, Nov. 4, 2024 /PRNewswire/ -- Arsenal Capital Partners ("Arsenal"), a leading private equity firm specializing in building technology-rich,…